JP7254370B2 - 無水硫酸ナトリウム、硫酸カリウム、無水硫酸マグネシウム及びシメチコンを含む結腸下剤の経口投与用固形製剤組成物 - Google Patents
無水硫酸ナトリウム、硫酸カリウム、無水硫酸マグネシウム及びシメチコンを含む結腸下剤の経口投与用固形製剤組成物 Download PDFInfo
- Publication number
- JP7254370B2 JP7254370B2 JP2020571688A JP2020571688A JP7254370B2 JP 7254370 B2 JP7254370 B2 JP 7254370B2 JP 2020571688 A JP2020571688 A JP 2020571688A JP 2020571688 A JP2020571688 A JP 2020571688A JP 7254370 B2 JP7254370 B2 JP 7254370B2
- Authority
- JP
- Japan
- Prior art keywords
- sulfate
- simethicone
- water
- oral administration
- anhydrous magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/2036—Silicones; Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、結腸下剤中の主成分として新規な原料を使用する新薬製剤に関するものである。また、本発明は、無水硫酸ナトリウム、硫酸カリウム、無水硫酸マグネシウム及びシメチコンなどの従来存在しなかった主成分を含み、服薬コンプライアンスを改善した、結腸下剤の経口投与用固形製剤組成物に関するものである。
Claims (2)
- 無水硫酸マグネシウム、硫酸カリウム、無水硫酸ナトリウム及びシメチコンを含む結腸下剤の錠剤であって、滑沢剤を添加することなく製剤に製造されている錠剤。
- 錠剤が、大腸内視鏡検査の前日と当日に分けて投与され、
総服用量が以下のとおり:
無水硫酸マグネシウム 2880.08mg
硫酸カリウム 5629.96mg
無水硫酸ナトリウム 31500.0mg
シメチコン 320.04mg
である、請求項1に記載の錠剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180069785A KR102111094B1 (ko) | 2018-06-18 | 2018-06-18 | 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물 |
KR10-2018-0069785 | 2018-06-18 | ||
PCT/KR2019/006311 WO2019245177A1 (ko) | 2018-06-18 | 2019-05-27 | 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022502344A JP2022502344A (ja) | 2022-01-11 |
JP7254370B2 true JP7254370B2 (ja) | 2023-04-10 |
Family
ID=68984159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020571688A Active JP7254370B2 (ja) | 2018-06-18 | 2019-05-27 | 無水硫酸ナトリウム、硫酸カリウム、無水硫酸マグネシウム及びシメチコンを含む結腸下剤の経口投与用固形製剤組成物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US11439601B2 (ja) |
EP (1) | EP3808354A4 (ja) |
JP (1) | JP7254370B2 (ja) |
KR (1) | KR102111094B1 (ja) |
CN (1) | CN112292136A (ja) |
PH (1) | PH12020552098A1 (ja) |
WO (1) | WO2019245177A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20240075060A1 (en) * | 2020-12-31 | 2024-03-07 | Taejoon Pharmaceutical Co., Ltd. | Oral solid formulation for colon cleansing |
KR20230140488A (ko) | 2022-03-22 | 2023-10-06 | 주식회사 대웅테라퓨틱스 | 장 정결용 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001106632A (ja) | 1999-09-07 | 2001-04-17 | Mcneil Ppc Inc | 緩下剤の効力を高める方法及び組成物 |
JP2015510491A (ja) | 2011-10-27 | 2015-04-09 | ボロディー,トーマス・ジュリウス | 電解質下剤 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01125319A (ja) * | 1987-11-11 | 1989-05-17 | Morishita Seiyaku Kk | 全腸管洗浄液用投与組成物 |
US5922351A (en) * | 1991-03-27 | 1999-07-13 | Bayer Corporation | Lubricants for use in tabletting |
US6946149B2 (en) | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
AU2015221520B2 (en) * | 2003-11-19 | 2017-06-08 | Salix Pharmaceuticals, Inc. | Colonic purgative composition with soluble binding agent |
US7687075B2 (en) | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
EP2322190B1 (en) * | 2009-11-02 | 2013-04-03 | Promefarm S.r.l. | Compositions for bowel cleansing and use thereof |
MX355760B (es) * | 2010-12-13 | 2018-04-27 | Salix Pharmaceuticals Inc | Formulaciones gástricas y colónicas y métodos para elaborar y usar las mismas. |
PT2696690T (pt) * | 2011-04-15 | 2017-12-22 | Braintree Laboratories Inc | Sais de sulfato como potenciador de tempo de trânsito |
KR101659746B1 (ko) | 2014-01-28 | 2016-09-26 | 주식회사한국파마 | 황산염을 함유하는 장관 하제 조성물 및 이의 제조 방법 |
KR102123078B1 (ko) | 2016-05-24 | 2020-06-15 | 주식회사 엘지화학 | 이차전지의 제조방법 |
KR102127003B1 (ko) | 2017-10-12 | 2020-06-25 | 주식회사 한국팜비오 | 황산염을 포함하는 대장 하제 조성물 |
-
2018
- 2018-06-18 KR KR1020180069785A patent/KR102111094B1/ko active IP Right Review Request
-
2019
- 2019-05-27 WO PCT/KR2019/006311 patent/WO2019245177A1/ko unknown
- 2019-05-27 JP JP2020571688A patent/JP7254370B2/ja active Active
- 2019-05-27 EP EP19822417.2A patent/EP3808354A4/en active Pending
- 2019-05-27 US US17/251,864 patent/US11439601B2/en active Active
- 2019-05-27 CN CN201980037448.1A patent/CN112292136A/zh active Pending
-
2020
- 2020-12-07 PH PH12020552098A patent/PH12020552098A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001106632A (ja) | 1999-09-07 | 2001-04-17 | Mcneil Ppc Inc | 緩下剤の効力を高める方法及び組成物 |
JP2015510491A (ja) | 2011-10-27 | 2015-04-09 | ボロディー,トーマス・ジュリウス | 電解質下剤 |
Non-Patent Citations (1)
Title |
---|
Clinical Trials NCT02523911,2015年08月,URL:https://clinicaltrials.gov/ct2/history/NCT02523911?A=1&B=1&C=merged#StudyPageTop |
Also Published As
Publication number | Publication date |
---|---|
US11439601B2 (en) | 2022-09-13 |
CN112292136A (zh) | 2021-01-29 |
JP2022502344A (ja) | 2022-01-11 |
US20210251908A1 (en) | 2021-08-19 |
PH12020552098A1 (en) | 2021-08-02 |
WO2019245177A1 (ko) | 2019-12-26 |
KR102111094B1 (ko) | 2020-05-14 |
KR20190142620A (ko) | 2019-12-27 |
EP3808354A1 (en) | 2021-04-21 |
EP3808354A4 (en) | 2021-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4801255B2 (ja) | 沸騰性酸−塩基対を含有する製薬学的組成物 | |
JP6067687B2 (ja) | 味覚マスキングのためのイオン交換樹脂を含有する可食性経口ストリップ又はウエハース剤形 | |
JP4608316B2 (ja) | イブプロフェンナトリウムの剤形 | |
RU2655797C2 (ru) | Применение лекарственного препарата традиционной китайской медицины для получения лекарственного препарата для предупреждения и/или лечения болезни крона | |
JP7254370B2 (ja) | 無水硫酸ナトリウム、硫酸カリウム、無水硫酸マグネシウム及びシメチコンを含む結腸下剤の経口投与用固形製剤組成物 | |
RU2762754C2 (ru) | Композиция для применения в предупреждении и/или лечении индуцированного онкологическим лечением мукозита полости рта и желудочно-кишечного тракта | |
JP4276545B2 (ja) | 改良組成物 | |
US20130189377A1 (en) | Compositions | |
KR102127003B1 (ko) | 황산염을 포함하는 대장 하제 조성물 | |
JP7359909B2 (ja) | 口腔用組成物の製造方法、口腔用組成物の口腔内塗布部との密着性を向上させる方法および口腔用組成物の口腔内塗布部における滞留性を向上させる方法。 | |
KR20230043086A (ko) | 장세척을 위한 경구용 고형제제 | |
KR20180091572A (ko) | 경구투여용 대장하제조성물 | |
RU2725743C2 (ru) | Продукт на основе хелата бис-глицината железа и альгиновой кислоты и/или ее водорастворимых солей, его составы и его фармацевтические применения | |
US20150147411A1 (en) | Composition for preventing or treating colitis comprising s-allyl-l-cysteine as active ingredient, and medical preparation comprising same | |
JP2014172855A (ja) | 口腔内速崩壊性錠剤 | |
JP2004522698A (ja) | 医薬組成物のための香料系およびそのような組成物の製造方法 | |
JP5563841B2 (ja) | 薬物の不快な味をマスキングした経口医薬組成物 | |
KR20170090364A (ko) | 하제 조성물 | |
KR20230140488A (ko) | 장 정결용 조성물 | |
IT201900000268A1 (it) | composizioni per il trattamento della costipazione | |
CN116801888A (zh) | 用于结肠清洁的口服固体制剂 | |
JP6150564B2 (ja) | 口腔内速崩壊性錠剤 | |
JP2021070685A (ja) | 固形製剤 | |
JP2003095936A (ja) | 消化器用医薬組成物 | |
JP2007137783A (ja) | 経口服用する徐放性の医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210803 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220628 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220712 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20221011 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221209 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230307 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230322 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7254370 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |